Global Diphtheria, Pertussis, and Tetanus Vaccine Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application

Diphtheria, pertussis, and tetanus (DPT) vaccine is administered for three infectious diseases in humans-diphtheria, tetanus, and pertussis. They are administered either in childhood or middle age to produce the acquired immunity against diphtheria, pertussis, and tetanus.

Market Analysis and Insights: Global Diphtheria, Pertussis, and Tetanus Vaccine Market
In 2020, the global Diphtheria, Pertussis, and Tetanus Vaccine market size was US$ 2522 million and it is expected to reach US$ 3296.6 million by the end of 2027, with a CAGR of 3.9% between 2021 and 2027
Global Diphtheria, Pertussis, and Tetanus Vaccine Scope and Market Size
The global Diphtheria, Pertussis, and Tetanus Vaccine market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Diphtheria, Pertussis, and Tetanus Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.

Segment by Type
DTaP
Td
Tdap

Segment by Application
Hospitals
Clinics
Vaccination Centers

By Company
Johnson & Johnson
GlaxoSmithKline
Sanofi
Lanzhou Institute of Biological
Merck
Novartis
AstraZeneca
Emergent
Astellas

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE